Global patterns in anaphylaxis due to specific foods: A systematic review - 03/12/21

Abstract |
Background |
There are increasing global data relating to prevalence of food allergy and food-induced anaphylaxis; however, this is often based on surrogate measures of sensitization rather than objective symptoms at food challenge. In terms of protecting food-allergic consumers from reactions, to our knowledge, there has been no global survey assessing geographic differences in the proportion of anaphylaxis triggered by specific foods.
Objective |
We sought to identify common triggers for food-induced anaphylaxis and how these vary from country to country.
Methods |
Systematic review of relevant reports published between January 2010 and November 2020. Results were reported following PRISMA guidelines. Publications were screened and data extracted by 2 independent reviewers, and the risk of bias was assessed.
Results |
Sixty-five studies (encompassing 41 countries and all 6 regions as defined by the Food and Agriculture Organization of the United Nations) were included. Significant regional variations in the most common triggers of food anaphylaxis were seen; however, in general, there was good agreement between local legislative requirements for allergen disclosure and the most common allergens for each region or nation.
Conclusions |
Local legislation for allergen disclosure generally reflects those allergens commonly responsible for food anaphylaxis. Cow’s milk and crustaceans appear to cause a higher proportion of anaphylaxis compared to peanut in some regions.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Key words : Allergen labeling, anaphylaxis, Codex, epidemiology, food allergy, prevalence
Abbreviations used : LTP, NASWP
Plan
| Funded by a UK Medical Research Council Clinician Scientist award to P. J. Turner (reference MR/K010468/1). P. J. Turner is supported through the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. |
|
| Disclosure of potential conflict of interest: P. J. Turner reports grants from UK Medical Research Council, NIHR/Imperial BRC, UK Food Standards Agency, and J. M. Charitable Foundation during the conduct of the study; and personal fees from UK Food Standards Agency, Aimmune Therapeutics, Allergenis, and ILSI Europe outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 148 - N° 6
P. 1515 - décembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
